AngioDynamics(ANGO)近日披露了其2026财年第三季度财务报告。财报显示,公司医疗科技(Med Tech)业务板块延续了强劲的增长势头,实现了双位数的同比增长。这一核心业务的优异表现,成为推动公司整体盈利能力持续提升的关键动力。
AngioDynamics(ANGO)近日披露了其2026财年第三季度财务报告。财报显示,公司医疗科技(Med Tech)业务板块延续了强劲的增长势头,实现了双位数的同比增长。这一核心业务的优异表现,成为推动公司整体盈利能力持续提升的关键动力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.